Oruka Therapeutics, Inc.
Public company- Headquarters
- MENLO PARK, California
- Ticker
- ORKA
- CIK
- 0000907654
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Chief Commercial OfficerTodd Edwards | Aug 24, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- ACADIA PHARMACEUTICALS INC
Executive Vice President, Head of Research and Development departs: Elizabeth H.Z. Thompson, Ph.D.
- KYNTRA BIO, INC.
Class III director appointed: Andrew E. Singer, MBA
- BIOMARIN PHARMACEUTICAL INC
WARN notice: Novato, CA
- CORCEPT THERAPEUTICS INC
President of Corcept Endocrinology departs: Sean Maduck
- Executive appointment
Chief Commercial Officer appointed: Todd Edwards
Todd Edwards was named Chief Commercial Officer of Oruka Therapeutics, Inc., effective August 24, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 24, 2026Role: Chief Commercial Officer
Only one public record so far. We add events as soon as a new filing lands; watch Oruka Therapeutics, Inc. to get them in your digest.
Last verified Nov 8, 2026